A direct method for the identification of patterns of care using administrative databases: the case of breast cancer.
Journal
The European journal of health economics : HEPAC : health economics in prevention and care
ISSN: 1618-7601
Titre abrégé: Eur J Health Econ
Pays: Germany
ID NLM: 101134867
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
30
04
2020
accepted:
27
05
2021
pubmed:
28
7
2021
medline:
3
11
2021
entrez:
27
7
2021
Statut:
ppublish
Résumé
To identify and provide lists of procedures and drugs related to diagnosis and treatment of breast cancer. These lists can be used for the estimation of the cost of illness. The method consists of identifying lists of procedures/interventions/drugs related to the tumour of interest, drawn by a panel of expert clinicians and oncologists on the basis of clinical guidelines and current practice. The lists are applied to data referring to breast cancer female patients, collected by population-based Cancer Registries and linked at individual level with information on health care treatments. A comparison with lists obtained via the matched control method is implemented. The distribution of administered procedures and drug prescriptions is coherent with the patient clinical pathway: surgery is the main cause of hospitalization in the first year since diagnosis, diagnostic and monitoring interventions are more frequent in the following years (recurrences detection), and at end-of-life (palliative care). Most outpatient services are due to diagnosis and monitoring, one third of services in the first year since diagnosis is radiotherapy and chemotherapy. Drugs prescribed to patients and sold in pharmacy include hormonal drugs as first course treatment and analgesics as palliative care. This direct method represents a valid alternative to the matched control method in describing patterns of care and costs related to the entire disease pathway. It is particularly suitable in case of cancer sites with complex patterns of care, such as breast cancer. The lists of codes developed here are based on international classification systems and can be easily applicable to other countries.
Identifiants
pubmed: 34312745
doi: 10.1007/s10198-021-01327-8
pii: 10.1007/s10198-021-01327-8
pmc: PMC8558165
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1477-1485Subventions
Organisme : Ministero della Salute
ID : PROGRAMMA CCM 2014
Organisme : European Commission
ID : Work Programme 2017, Grant Number 801520 HP-JA-2017 "Innovative Partnership for Action Against Cancer"
Informations de copyright
© 2021. The Author(s).
Références
Value Health. 2014 Jan-Feb;17(1):90-7
pubmed: 24438722
Eur J Health Econ. 2020 Sep;21(7):1003-1013
pubmed: 32399781
J Natl Cancer Inst. 2011 Jan 19;103(2):117-28
pubmed: 21228314
Cancer Med. 2019 Jan;8(1):94-103
pubmed: 30575329
Med Care. 2015 Apr;53(4):302-9
pubmed: 25749656
Pharmacoeconomics. 2006;24(9):869-90
pubmed: 16942122
J Natl Compr Canc Netw. 2018 Apr;16(4):402-410
pubmed: 29632060
Biometrics. 1946 Dec;2(6):110-4
pubmed: 20287815
J Natl Cancer Inst Monogr. 2013;2013(46):88-98
pubmed: 23962512
J Allergy Clin Immunol. 2015 Dec;136(6):1517-1522
pubmed: 26483176